Diversity, Equity & Inclusion Committee

 

DEI Committee Chair, Vice Chair & Membership Application Announcement

NRG Oncology accepting applications for members and the positions of Chair and Vice Chair, Diversity, Equity & Inclusion Committee

Application Deadline: September 30th, 2022

NRG Oncology is seeking applications for the positions of chair, vice chair, and member of its newly formed Diversity, Equity & Inclusion (DEI) Committee. The NRG DEI Committee is charged with developing and implementing programs and policies to foster diversity, equity, and inclusion within NRG that impact its committees and membership. More information about this new committee can be found HERE. Candidates for committee membership should demonstrate a willingness to provide timely collaboration with members and liaisons of the various NRG committees and staff, as well as with other professional societies, and to address common concerns in support of NRG’s mission and scientific focus. Candidates for the Chair and Vice Chair positions should also demonstrate a history of mentorship. Candidates should indicate in their cover letter if in addition to committee membership they want to be considered for a chair and/or vice chair position.

NRG Oncology committee members, chairs, and vice chairs must be at an NRG Oncology member Institution. Applicants for the chair and vice chair positions must be eligible to receive federal funding as nominal support is provided to those positions to offset related effort and travel to NRG Oncology meetings.

Applicants should forward a cover letter addressing their specific interests and qualifications for the position(s) as well as an NIH biosketch to committee-nominations@nrgoncology.org. The deadline for application submission is September 30, 2022. If you have questions about the position or application process, please email the address above and we will have an appropriate party get back to you.

Our Mission

Improve the lives of cancer patients by conducting practice-changing multi-institutional clinical and translational research

Quick Facts

  • 150 Years cumulative research experience
  • 150 Years cumulative research experience
  • 150 Years cumulative research experience

Scientific Plan and Structure Established for NRG Oncology

With the submission of the NRG Oncology grant proposal to the National Cancer Institute (NCI) on January 15, the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG) took the formal step toward becoming the cancer clinical cooperative group NRG Oncology. These three groups have more than 150 years' cumulative experience in conducting practice-defining, multiinstitutional phase II and III trials sponsored primarily by the NCI, as well as a history of undertaking the kind of phase I trials and translational biological studies that will be imperative for future clinical cancer research.

The three legacy groups will continue to carry out NCI-supported trials as independent but collaborative entities through February 2014, with 96 total trials open for patient accrual and 68 trials in development. If all goes as planned, beginning in March 2014, all federal research activities of the merged group will be managed under the auspices of the NRG Oncology Operations Center. The three current chairs, Quynh-Thu Le, MD; Robert Mannel, MD; and Norman Wolmark, MD, will serve as NRG Oncology principal investigators (PIs) and share equal responsibility for executing the group’s research program.

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.